Pharma Newspress
Pharma Jobs PostThis is our small initiative to share pharmaceutical as well as healthcare related updates with our subscribers
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 38 | Subscribers | Read | linkedin.com |
Curious about how many subscribers Pharma Newspress has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Piramal Pharma Solutions' Ahmedabad Site Clears FDA Inspection with a No Action Indicated (NAI)
Piramal Pharmaceutical Development Services (PPPDS) Ahmedabad facility has successfully completed an FDA inspection, unlocking access to advanced FDA-approved analytical capabilities for our customers. This includes comprehensive services s...
Lupin Partners with Huons Co. Ltd to Bring Cyclosporine Ophthalmic Nanoemulsion to Mexico
Lupin signed a license and supply agreement with Huons Co., Ltd. for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, 0.4mL Single-use Vial, in Mexico.
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg.
Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Capsules USP, 15 mg and 25 mg.
TAKEDA AND BIOLOGICAL E. LIMITED COLLABORATE TO ACCELERATE ACCESS TO DENGUE VACCINE IN ENDEMIC AREAS
* Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest
Authors
The writers behind this newsletter.
Frequently Asked Questions
How can I access the email archive for Pharma Newspress?
You can find recent issues that have been published by Pharma Newspress on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Pharma Newspress have?
To see how many people subscribe to Pharma Newspress, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Pharma Newspress?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Pharma Newspress as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Pharma Newspress?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Pharma Newspress using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Pharma Newspress?
Scroll up to where it says Similar Newsletters to see other publications like Pharma Newspress. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Pharma Newspress?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.